Literature DB >> 1741920

Activation of mononuclear immune cells in response to staphylococcal lipoteichoic acid.

Y Ohshima1, H L Ko, J Beuth, H Burrichter, K Oette, G Pulverer.   

Abstract

The goal of the present study was to evaluate the influence of staphylococcal lipoteichoic acid (LTA) on the activation of mononuclear immune cells. A murine tumor necrosis-like factor (TNF-like) was induced in the sera of CD-1 mice which had been primed with heat/formalin-inactivated Propionibacterium avidum KP-40 and subsequently exposed to LTA extracted from Staphylococcus saprophyticus strain S 1. Monoclonal antibody against murine TNF (anti-TNF) significantly inhibited the cytostatic activity of mice sera against transformed L-929 cells. Freshly isolated lymphocytes did not display interleukin 2 (Il-2) receptors, but receptors were expressed on Con A incubated cells and in significantly higher numbers after coexposure to staphylococcal LTA in vitro. Since the induction of TNF (macrophages) and Il-2 receptors (lymphocytes) represent stimulation of the mononuclear immune system, staphylococcal LTA may be considered to be an immunomodifier.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1741920     DOI: 10.1016/s0934-8840(11)80303-8

Source DB:  PubMed          Journal:  Zentralbl Bakteriol        ISSN: 0934-8840


  3 in total

Review 1.  Clinical and Biological Features of Cutibacterium (Formerly Propionibacterium) avidum, an Underrecognized Microorganism.

Authors:  Stéphane Corvec
Journal:  Clin Microbiol Rev       Date:  2018-05-30       Impact factor: 26.132

2.  Structural decomposition and heterogeneity of commercial lipoteichoic Acid preparations.

Authors:  Siegfried Morath; Armin Geyer; Ingo Spreitzer; Corinna Hermann; Thomas Hartung
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

3.  Behavior of lymphocyte subsets and expression of activation markers in response to immunotherapy with galactoside-specific lectin from mistletoe in breast cancer patients.

Authors:  J Beuth; H L Ko; H J Gabius; H Burrichter; K Oette; G Pulverer
Journal:  Clin Investig       Date:  1992-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.